300869 深市 康泰医学

          康泰医学系统（秦皇岛）股份有限公司

                2020 年度财务决算报告

    康泰医学系统（秦皇岛）股份有限公司（以下简称“公司”）2020 年度财务报
 告已经德勤华永会计师事务所（特殊普通合伙）审计，并出具了标准无保留意见的 审计报告。现就公司 2020 年主要财务指标及经营财务情况报告如下：
 一、主要财务数据和财务指标

                                        2020 年          2019 年      本年比上年增减

营业收入（万元）                          140,122.53        38,724.67          261.84%

归属于上市公司股东的净利润（万元）        61,339.54          7,378.12          731.37%

归属于上市公司股东的扣除非经常性损

益的净利润（万元）                          59,517.07          6,833.08          771.01%

资产总额（万元）                          209,782.83        67,920.29          208.87%

归属于上市公司股东的净资产（万元）        156,882.40        58,322.56          168.99%

经营活动产生的现金流量净额（万元）        59,773.36          5,021.83          1090.27%

基本每股收益（元/股）                          1.64            0.20          720.00%

加权平均净资产收益率                        62.43%          14.49%          47.94%

 注：全文以万元为单位可能导致尾差。
 二、主要财务数据、财务指标发生变动的情况及原因
 （一）资产状况分析

                                                                        单位：万元

          项目                本年年末余额        上年年末余额        变动幅度

 货币资金                              81,406.60          18,430.24            341.70%

 应收账款                              10,166.65            5,403.11              88.16%

 预付款项                              1,162.44            629.49              84.66%

 其他应收款                              404.67            361.80              11.85%

 存货                                  28,442.20          12,807.65            122.07%

 其他流动资产                          5,137.29            882.13            482.37%

 流动资产合计                        126,719.86          38,514.42            229.02%

 投资性房地产                          2,222.14            2,395.73              -7.25%

 固定资产                              14,728.12            7,228.89            103.74%

 在建工程                                386.03                  -

 无形资产                              1,307.37            1,524.37            -14.24%

长期待摊费用                                  -              86.23              不适用

递延所得税资产                          373.03                  -              不适用

其他非流动资产                        64,046.28          18,170.65            252.47%

非流动资产合计                        83,062.98          29,405.87            182.47%

资产总计                            209,782.83          67,920.29            208.87%

  报告期末，公司总资产为 209,782.83 万元，较上年末 67,920.29 万元增幅

208.87%，其中流动资产占总资产比为 60.41%，非流动资产占比 39.59%。

  1、货币资金本报告期期末金额 81,406.60 万元，较期初增加 62,976.36

万元，增幅 341.70%,主要系本报告期公司首次公开发行股票募集资金；产销规模增加，收到的货款增加。

  2、应收账款本报告期期末金额 10,166.65 万元，较期初增加 4,763.54 万元，
增幅 88.16%,主要系本报告期内销售额增加所致。

  3、预付账款本报告期期末金额 1,162.44 万元，较期初增加 532.95 万元，增
幅 84.66%,主要系本报告期预付原材料款增加所致。

  4、存货本报告期期末金额 28,442.20 万元，较期初增加 15,634.55 万元，增幅
122.07% ,主要系本报告期内销售增加、采购和生产备货增加所致。

  5、其他流动资产本报告期期末金额 5,137.29 万元，较期初增加 4,255.16 万元，
增幅 482.37%,主要系本报告期内购买收益凭证所致。

  6、固定资产本报告期期末金额 14,728.12 万元，较期初增加 7,499.23 万元，
增幅 103.74%，主要原因系：（1）购置募投项目智能医疗设备产业研究院办公楼；（2）购建生产用机器设备。

  7、在建工程本报告期期末金额 386.03 万元，较期初增加 386.03 万元，主要系
本报告期医疗设备生产改扩建募投项目开工所致。

  8、其他非流动资产本报告期期末金额 64,046.28 万元，较期初增加 45,875.63
万元，增幅 252.47%，主要系本报告期内定期存款增加所致。
（二）负债及所有者权益状况分析

                                                                      单位：万元

          项目                本年年末余额        上年年末余额        变动幅度

短期借款                              26,793.53              1,887.53        1,319.50%

应付账款                                9,336.41              3,307.33          182.29%

预收款项                                      -              1,257.32          不适用

合同负债                                3,856.64                    -          不适用

应付职工薪酬                            1,536.02                649.15          136.62%

应交税费                                9,671.25                769.63        1,156.61%

其他应付款                                298.65                244.83          21.98%

流动负债合计                          51,492.50              8,115.80        534.47%

递延所得税负债                            249.53                20.21        1,134.69%

递延收益                                1,158.40              1,461.72          -20.75%

非流动负债合计                          1,407.93              1,481.93          -4.99%

负债合计                              52,900.43              9,597.73        451.18%

股本                                  40,179.68            36,079.68          11.36%

资本公积                              34,498.12              1,197.36        2,781.18%

盈余公积                              10,404.88              4,222.28          146.43%

其他综合收益                              -15.11                165.35        -109.14%

未分配利润                            71,814.83            16,657.89          331.12%

归属于母公司股东权益合计              156,882.40            58,322.56        168.99%

少数股东权益                                  -                    -                -

股东权益合计                          156,882.40            58,322.56        168.99%

负债和股东权益总计                    209,782.83